More Countries Abandon Chinese COVID Shots, Signaling a Setback to Regime’s ‘Vaccine Diplomacy’

More Countries Abandon Chinese COVID Shots, Signaling a Setback to Regime’s ‘Vaccine Diplomacy’
Health workers administer the AstraZeneca COVID-19 vaccines to the elderly at Central Vaccination Center in Bang Sue Grand Station in Bangkok, Thailand, on July 13, 2021. Sirachai Arunrugstichai/Getty Images
Updated:
More Asian countries are abandoning Chinese vaccines and a Pacific Island nation had delayed the approval of them amid concerns raised about their reduced protection levels against CCP virus infections, giving more validation to a recent suggestion that the window of opportunity is narrowing for the Chinese Communist Party’s (CCP) so-called “vaccine diplomacy.”

Millions of people have received Chinese-made Sinovac or Sinopharm vaccines across Asia, but Thailand and Indonesia in the past month decided to drop the Chinese vaccines as their main approach against COVID-19, the disease caused by the CCP virus.

Jenny Li has contributed to The Epoch Times since 2010. She has reported on Chinese politics, economics, human rights issues, and U.S.-China relations. She has extensively interviewed Chinese scholars, economists, lawyers, and rights activists in China and overseas.
Related Topics